Recruiting Chronic Kidney Disease Studies in Minneapolis
About Chronic Kidney Disease Clinical Trials in Minneapolis
Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years. It affects about 10% of the global population and can lead to end-stage renal disease requiring dialysis or transplant. Management includes controlling blood pressure, blood sugar, and using newer agents like SGLT2 inhibitors.
There are currently 2 chronic kidney disease clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 1,020 participants. Research is being sponsored by Icahn School of Medicine at Mount Sinai, Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Chronic Kidney Disease Clinical Trials in Minneapolis — FAQ
Are there chronic kidney disease clinical trials in Minneapolis?
Yes, there are 2 chronic kidney disease clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Minneapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.
Are clinical trials in Minneapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.
What chronic kidney disease treatments are being tested?
The 2 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for chronic kidney disease.
Data updated July 19, 2026 from ClinicalTrials.gov